Acta neurochirurgica · 2025
Intra-articular steroid injections for lumbar disk herniation: a systematic review and meta-analysis.
Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gill SS, Ramkumar P, Kamath AG, Kanakala S, Anil A, Namireddy SR, Yalavarthy S, Ramsay DSC, Salih A, Thavarajasingam A, Prashar A, K SV, Beutel T, Russo S, Thavarajasingam SG, Ponniah HS
Аннотация
INTRODUCTION: Lumbar disc herniation (LDH) is one of the most common causes of lower back pain, radiculopathy, and functional impairment. Intra-articular (IA) steroid injections, including transforaminal (TFESI), interlaminar (IESI), and caudal (CESI) epidural steroid injections, are commonly administered to alleviate these symptoms when surgery is not indicated or opted for. This systematic review and meta-analysis evaluates the efficacy of these injection modalities in reducing pain and disability in LDH patients.
METHODS: Following PRISMA, 19,664 studies on IA steroid injections for LDH were screened, yielding 41 eligible studies. Random-effects and fixed effects meta-analyses computed pooled standardized mean changes (SMC), depending on heterogeneity (I2).
RESULTS: TFESI showed strong short-term efficacy, with the greatest pooled NRS improvement of -5.15 (95% CI: -6.59, -3.72, p < 0.001, I2 = 99.14%) at 3 months and the largest VAS reduction of -30.53 (95% CI: -43.89, -17.17, p < 0.001, I2 = 99.99%) at 3 months. CESI had the highest ODI improvement at 1 month (-18.99, 95% CI: -26.88, -11.10, p < 0.001, I2 = 99.35%), while IESI demonstrated the greatest ODI reduction at 6 months (-16.06, 95% CI: -16.83, -15.28, p < 0.001, I2 = 18.85%).
CONCLUSION: This meta-analysis suggests that IA injections may relieve LDH symptoms, with TFESI showing the greatest pain relief and functional improvement. However, significant heterogeneity calls for standardized protocols and further research. Demographic factors minimally influenced outcomes, whereas methodological variability underscores treatment complexity. Future studies should emphasize methodological consistency and personalized approaches to optimize patient outcomes.
METHODS: Following PRISMA, 19,664 studies on IA steroid injections for LDH were screened, yielding 41 eligible studies. Random-effects and fixed effects meta-analyses computed pooled standardized mean changes (SMC), depending on heterogeneity (I2).
RESULTS: TFESI showed strong short-term efficacy, with the greatest pooled NRS improvement of -5.15 (95% CI: -6.59, -3.72, p < 0.001, I2 = 99.14%) at 3 months and the largest VAS reduction of -30.53 (95% CI: -43.89, -17.17, p < 0.001, I2 = 99.99%) at 3 months. CESI had the highest ODI improvement at 1 month (-18.99, 95% CI: -26.88, -11.10, p < 0.001, I2 = 99.35%), while IESI demonstrated the greatest ODI reduction at 6 months (-16.06, 95% CI: -16.83, -15.28, p < 0.001, I2 = 18.85%).
CONCLUSION: This meta-analysis suggests that IA injections may relieve LDH symptoms, with TFESI showing the greatest pain relief and functional improvement. However, significant heterogeneity calls for standardized protocols and further research. Demographic factors minimally influenced outcomes, whereas methodological variability underscores treatment complexity. Future studies should emphasize methodological consistency and personalized approaches to optimize patient outcomes.